Template:Adrenocortical carcinoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Adrenocortical carcinoma (patient information)|Patient Info]]
[[Adrenocortical carcinoma (patient information)|Patient Information]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Adrenocortical carcinoma epidemiology and demographics|Epidemiology & Demographics]]
[[Adrenocortical carcinoma epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 76: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Adrenocortical carcinoma natural history|Natural History, Complications & Prognosis]]
[[Adrenocortical carcinoma natural history|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 94: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Adrenocortical carcinoma history and symptoms|History & Symptoms]]
[[Adrenocortical carcinoma history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 160: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Adrenocortical carcinoma surgery|Surgical Therapy]]
[[Adrenocortical carcinoma surgery|Surgery]]
|-  
|-  
!
!
Line 172: Line 172:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Adrenocortical carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Adrenocortical carcinoma primary prevention|Primary prevention]]
|-  
!
|- bgcolor="PaleTurquoise"
!
 
|- bgcolor="PaleTurquoise"
!
[[Adrenocortical carcinoma secondary prevention|Secondary prevention]]
|-  
|-  
!  
!  


[[Adrenocortical carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!

Latest revision as of 17:13, 3 October 2017